Chesi M - Search Results

1

Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.

Baughn LB, Jessen E, Sharma N, Tang H, Smadbeck JB, Long MD, Pearce K, Smith M, Dasari S, Sachs Z, Linden MA, Cook J, Keith Stewart A, Chesi M, Mitra A, Leif Bergsagel P, Van Ness B, Kumar SK. Baughn LB, et al. Among authors: chesi m. Blood Cancer J. 2023 May 22;13(1):84. doi: 10.1038/s41408-023-00851-5. Blood Cancer J. 2023. PMID: 37217482 Free PMC article.

2

Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma.

Cao S, Liu J, Chesi M, Bergsagel PL, Ho IC, Donnelly RP, Ma X. Cao S, et al. Among authors: chesi m. J Immunol. 2002 Nov 15;169(10):5715-25. doi: 10.4049/jimmunol.169.10.5715. J Immunol. 2002. PMID: 12421951

3

Maintained rules of development in a mouse B-cell tumor.

Robbiani DF, Colon K, Affer M, Chesi M, Bergsagel PL. Robbiani DF, et al. Among authors: chesi m. Leukemia. 2005 Jul;19(7):1278-80. doi: 10.1038/sj.leu.2403774. Leukemia. 2005. PMID: 15843816 No abstract available.

4

Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.

Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM. Chesi M, et al. Blood. 1996 Jul 15;88(2):674-81. Blood. 1996. PMID: 8695815 Free article.

5

Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.

Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schröck E, Ried T, Kuehl WM. Chesi M, et al. Blood. 1998 Jun 15;91(12):4457-63. Blood. 1998. PMID: 9616139 Free article.

6

The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.

Chesi M, Nardini E, Lim RS, Smith KD, Kuehl WM, Bergsagel PL. Chesi M, et al. Blood. 1998 Nov 1;92(9):3025-34. Blood. 1998. PMID: 9787135 Free article.

7

Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis.

Plowright EE, Li Z, Bergsagel PL, Chesi M, Barber DL, Branch DR, Hawley RG, Stewart AK. Plowright EE, et al. Among authors: chesi m. Blood. 2000 Feb 1;95(3):992-8. Blood. 2000. PMID: 10648414 Free article.

8

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma.

Chesi M, Brents LA, Ely SA, Bais C, Robbiani DF, Mesri EA, Kuehl WM, Bergsagel PL. Chesi M, et al. Blood. 2001 Feb 1;97(3):729-36. doi: 10.1182/blood.v97.3.729. Blood. 2001. PMID: 11157491 Free article.

9

The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells.

Li Z, Zhu YX, Plowright EE, Bergsagel PL, Chesi M, Patterson B, Hawley TS, Hawley RG, Stewart AK. Li Z, et al. Among authors: chesi m. Blood. 2001 Apr 15;97(8):2413-9. doi: 10.1182/blood.v97.8.2413. Blood. 2001. PMID: 11290605 Free article.

10

Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma.

Trudel S, Ely S, Farooqi Y, Affer M, Robbiani DF, Chesi M, Bergsagel PL. Trudel S, et al. Among authors: chesi m. Blood. 2004 May 1;103(9):3521-8. doi: 10.1182/blood-2003-10-3650. Epub 2004 Jan 8. Blood. 2004. PMID: 14715624 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page